Efficacy of a Novel Zigzag Application Pattern for Micropulse Transscleral Cyclophotocoagulation for the Management of Glaucoma

被引:0
|
作者
Sami, Ahmed [1 ,3 ]
Aboulnasr, Tarek T. [2 ]
El-Shahed, Ahmed F. [1 ]
机构
[1] Helwan Univ, Fac Med, Cairo, Egypt
[2] Benha Univ, Fac Med, Cairo, Egypt
[3] Helwan Univ, Fac Med, Mokattam City Sq, Cairo 11571, Egypt
关键词
cyclophotocoagulation; laser treatment; refractory glaucoma; micropulse; zigzag; OUTCOMES;
D O I
10.1097/IJG.0000000000002095
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Precis:A zigzag mode of application effectively lowered IOP in glaucoma patients at 6 months with a low incidence of complications despite the longer application time. Comparative studies to assess the potential advantages of treating a larger area of ciliary body with this approach are needed. Purpose:The purpose of this study is to evaluate the clinical outcome of micropulse transscleral laser cyclophotocoagulation with zigzag mode of application in adult glaucomatous patients. Subjects and Methods:A prospective single-arm clinical trial included a series of 34 eyes of 30 consecutive patients who underwent micropulse transscleral cyclophotocoagulation (MP-TSCPC) with zigzag technique at a private ophthalmology center. The trial was conducted from March 16, 2021 to April 12, 2021. Patients who had at least 6 months of follow-up were included. MP-TSCPC probe was moved for 2 mm perpendicular to a line 3 mm parallel to the cornea. This aims to cover the largest circumference of the area supposed to hinder the cilliary body. The probe is moved over 3 quadrants for 90 seconds for each quadrant (total 270 s). Defined as an intraocular pressure (IOP) of 6 to 21 mm Hg or a reduction of IOP by 30%. Failure was defined as an inability to meet the criteria for success or need for retreatment. Results:The mean age of involved patients was 52.9 (& PLUSMN;SD: 3.9) years old. The mean IOP before MP-TSCPC was 37.47 (& PLUSMN;SD: 11.08) mm Hg, which was significantly reduced to 17.7 (& PLUSMN;SD: 7.4) mm Hg in the last follow-up visit at 6 months. Number of medications showed significant reduction from mean 3.44 (& PLUSMN;SD: 0.99) to 1.91 (& PLUSMN;SD: 1.26) in the last follow-up. Success rate was found to be 88% (30 out of 34 eyes) at the final follow-up, where 9 cases showed complete success (26.5%), whereas 21 (61.8%) cases showed qualified success. Despite the relatively higher parameters used in our study, no cases reported postoperative complications apart from only 1 case of reduced visual acuity by 1 line. Conclusions:A zigzag mode of application effectively lowered IOP in glaucoma patients at 6 months with a low incidence of complications despite the longer application time. Comparative studies to assess the potential advantages of treating a larger area of ciliary body with this approach are needed.
引用
收藏
页码:382 / 388
页数:7
相关论文
共 50 条
  • [41] Micropulse Transscleral Cyclophotocoagulation in Refractory Glaucoma. 6 month follow-up
    Del Hierro, Clarisa
    Alvarez Ascencio, Daniela
    Prado Larrea, Carolina
    Jimenez Roman, Jesus
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [42] Pars plicata versus pars plana application of micropulse transscleral cyclophotocoagulation
    Waibel, Soeren
    Herber, Robert
    Pillunat, Lutz E.
    Pillunat, Karin R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [43] Short-term Clinical Outcomes of Micropulse Transscleral Cyclophotocoagulation in Refractory Glaucoma Patients
    Suh, Jae Shin
    Yoo, Young Cheol
    Chung, Jae Keun
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2020, 61 (04): : 367 - 375
  • [44] Transscleral cyclophotocoagulation with MicroPulse® laser versus cyclophotocoagulation with continuous diode laser in patients with open-angle glaucoma
    Sofia Fili
    Iraklis Vastardis
    Georgios Perdikakis
    Markus Kohlhaas
    International Ophthalmology, 2022, 42 : 525 - 539
  • [45] Micropulse transscleral cyclophotocoagulation: initial results using a reduced energy protocol in refractory glaucoma
    Niten Vig
    Sally Ameen
    Philip Bloom
    Laura Crawley
    Eduardo Normando
    Alastair Porteous
    Faisal Ahmed
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2020, 258 : 1073 - 1079
  • [46] Comparison of safety and effectiveness of micropulse transscleral cyclophotocoagulation and "slow cook" diode laser transscleral cyclophotocoagulation in patients with refractory open-angle glaucoma
    Russ, Heloisa Helena Abil
    Seixas, Regina Cele Silveira
    Maestrini, Heloisa Andrade
    Balbino, Marcos
    Fernandes, Thatiana Almeida Pereira
    Lima, Nubia Vanessa dos Anjos
    Lopes, Nara Lidia Vieira
    Neto, Taurino dos Santos Rodrigues
    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2025, 88 (01)
  • [47] Micropulse transscleral cyclophotocoagulation: initial results using a reduced energy protocol in refractory glaucoma
    Vig, Niten
    Ameen, Sally
    Bloom, Philip
    Crawley, Laura
    Normando, Eduardo
    Porteous, Alastair
    Ahmed, Faisal
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2020, 258 (05) : 1073 - 1079
  • [48] Micropulse transscleral cyclophotocoagulation using a standard protocol in patients with refractory glaucoma naive of cyclodestruction
    Souissi, Soufiane
    Baudouin, Christophe
    Labbe, Antoine
    Hamard, Pascale
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (01) : 112 - 119
  • [49] Micropulse cyclophotocoagulation compared to continuous wave cyclophotocoagulation for the management of refractory pediatric glaucoma
    Wang, Bo
    Wallace, Ryan T.
    Musser, John A.
    Chaya, Craig J.
    Kraus, Courtney L.
    PLOS ONE, 2024, 19 (01):
  • [50] Short-term Efficacy and Safety of Micropulse Transscleral Cyclophotocoagulation in Korean Patients
    Kim, Jonghwa
    Sung, Mi Sun
    Park, Sang Woo
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2020, 61 (09): : 1072 - 1078